期刊文献+

奥施康定治疗中重度癌痛临床疗效观察 被引量:2

Clinical observation of oxycontin in managem entofmoderate and severe cancerpain
原文传递
导出
摘要 目的观察奥施康定(盐酸羟考酮控释片)治疗中重度癌痛的疗效及不良反应。方法采用开放试验方法,对95例中重度癌痛患者进行治疗。奥施康定起始剂量10mg/12h,根据疼痛缓解程度调整剂量,评价镇痛效果和不良反应。结果 95例中重度癌痛患者,总有效率85.3%,中度疼痛组有效率90.9%,重度疼痛组有效率83.6%。不良反应主要为便秘31例(32.6%)。结论奥施康定治疗中重度癌痛疗效确切,不良反应轻,服用安全。 Objective To observe analgesic effect andmain side effects of oxycontin inmanagement of themode rate and severe cancer pain.Methods Nintyfive patients with moderate and severe cancer pain were selected.Oxycontin was administered at an initial dose of 10mg every 12h and titrated upwards according to the extent of pain relief.Outcomes included analgesic effect and side effect.Results Among all the 95 patients total effective ratewas 85.3%,effective rate of themoderate and severe cancer pain was 90.9% and 83.6%,respectively.Main adverse effect was constipation in 31 patients(32.6%).Conclusion Oxycontin is safe and effective and with slight adverse effects in treatment ofmoderate and sever cancer pain.
作者 田亚丽
出处 《首都医药》 2012年第8期37-38,共2页 Capital Medicine
关键词 奥施康定 癌痛 疗效 不良反 oxycontin cancer pain curative effect adverse effect
  • 相关文献

参考文献6

二级参考文献25

  • 1刘华,王蔚,郑垂志,邢雪花.癌症三阶梯止痛563例分析[J].中国肿瘤临床,2004,31(23):1346-1348. 被引量:79
  • 2李小梅,刘端祺,李红英,王艳梅.恶性肿瘤患者临终前的阿片类药物止痛回顾[J].中国肿瘤临床,2005,32(23):1358-1360. 被引量:36
  • 3张冠中,谢晓冬,刘大为.盐酸羟考酮控释片治疗晚期癌症疼痛的临床应用[J].中国肿瘤临床,2007,34(2):72-74. 被引量:25
  • 4Kapil R, Nolting A, Roy P, et al. Pharmacokinedc properties of combination oxycodone plus racemic ibuprofen : two randomized, open-label, crossover studies in healthy adult volunteers Ⅱ. Clin Ther, 2004,26 : 2015 - 2025.
  • 5Arcuri E, Ginobbi P, Tirelli W, et al. Preliminary in vivo experimental evidence on intrammoral moohine uptake. Possible clinica/impficafions in cancer pain and opioid pesponsiveness. J Pain Symptom Manage,2002,24 : 1 - 3.
  • 6Clohisy DR, Mantyh PW. Bone cancer paill. Cancer,2003,79 (3 Suppl ) :866 - 873.
  • 7Smith MT, Ross FB, Nielsen CK, et al. Oxycodone has a distincdy different pharmacology from morphine. Eur J Pain,2001,5(suppl. A) : 135 - 136.
  • 8Hermos JA, Young MM, Gagnon DR, et al. Characterizations of long-term oxycodone/acetamino-phen prescril:, tions in veteran patients. Arch Intern Med,2004,164:2361 -2366.
  • 9Hongming Pan, Zaiyun Zhang,et al. Efficacy and tolerability of oxycodone HC1 controlled-release tablets on moderate to severe cancer pain. Clin Drug Invest. 2007,27(4):259-267.
  • 10Greiner W, Lehmann K, Earnshaw S, et al. Economic evaluation of Durogesic in moderate to severe, nonmalignant ,chronic pain in Germany. EurJ Econ. 2006, 7(4): 290-296.

共引文献83

同被引文献19

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部